Literature DB >> 2895030

Serum lysyl oxidase activity in patients with various liver diseases.

M Sakamoto1, Y Murawaki, C Hirayama.   

Abstract

Serum lysyl oxidase activity was examined in patients with various liver diseases. The activity of the enzyme was detected mainly in the serum fraction of the supernatant 80% saturated with (NH4)2SO4, and its molecular weight was estimated to be about 30,000 by Sephadex G-150 column filtration. Mean serum lysyl oxidase activity in 18 healthy controls was 129 +/- 50 (+/- SEM) cpm/ml and was significantly increased in patients with acute hepatitis, chronic active hepatitis, alcoholic liver disease and primary biliary cirrhosis, but not in those with chronic inactive hepatitis or liver cirrhosis. Serum lysyl oxidase activity was not correlated with the histological grade of hepatic fibrosis, but appeared to reflect active hepatic fibrogenesis in patients with liver diseases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2895030     DOI: 10.1007/bf02776746

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  28 in total

1.  Pathologic scar formation. Morphologic and biochemical correlates.

Authors:  T R Knapp; R J Daniels; E N Kaplan
Journal:  Am J Pathol       Date:  1977-01       Impact factor: 4.307

2.  Immunological studies of bovine aorta lysyl oxidase: evidence for two forms of the enzyme.

Authors:  G P Vidal; J J Shieh; K T Yasunobu
Journal:  Biochem Biophys Res Commun       Date:  1975-01-02       Impact factor: 3.575

3.  Hepatic collagen proline hydroxylase activity in primary biliary cirrhosis.

Authors:  S Jain; P J Scheuer; J O McGee; S Sherlock
Journal:  Eur J Clin Invest       Date:  1978-02       Impact factor: 4.686

4.  Lysyl oxidase activity in human normal skins and postburn scars.

Authors:  T Hayakawa; N Hino; H Fuyamada; T Nagatsu; H Aoyama
Journal:  Clin Chim Acta       Date:  1976-09-06       Impact factor: 3.786

5.  Morphological criteria in viral hepatitis. Review by an international group.

Authors: 
Journal:  Lancet       Date:  1971-02-13       Impact factor: 79.321

6.  Lysyl oxidase and collagenase in experimental acute and chronic liver injury.

Authors:  E A Carter; M J McCarron; E Alpert; K J Isselbacher
Journal:  Gastroenterology       Date:  1982-03       Impact factor: 22.682

7.  Characterization of a structural glycoprotein from bovine ligamentum nuchae exhibiting dual amine oxidase activity.

Authors:  A Serafini-Fracassini; G Ventrella; M J Field; J Hinnie; N I Onyezili; R Griffiths
Journal:  Biochemistry       Date:  1981-09-15       Impact factor: 3.162

Review 8.  Lysyl oxidase.

Authors:  R C Siegel
Journal:  Int Rev Connect Tissue Res       Date:  1979

9.  Hepatic prolyl hydroxylase and collagen synthesis in patients with alcoholic liver disease.

Authors:  S W Mann; G C Fuller; J V Rodil; E I Vidins
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

10.  Increased lysyl oxidase activity in culture medium of nonparenchymal cells from fibrotic livers.

Authors:  A Konishi; H Iguchi; J Ochi; R Kinoshita; K Miura; H Uchino
Journal:  Gastroenterology       Date:  1985-10       Impact factor: 22.682

View more
  3 in total

Review 1.  Lysyl Oxidase: Its Diversity in Health and Diseases.

Authors:  Suchitra Kumari; Tarun Kumar Panda; Tapaswini Pradhan
Journal:  Indian J Clin Biochem       Date:  2016-05-11

2.  The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis.

Authors:  Franco Conforti; Elizabeth R Davies; Claire J Calderwood; Thomas H Thatcher; Mark G Jones; David E Smart; Sumeet Mahajan; Aiman Alzetani; Tom Havelock; Toby M Maher; Philip L Molyneaux; Andrew J Thorley; Teresa D Tetley; Jane A Warner; Graham Packham; A Ganesan; Paul J Skipp; Benjamin J Marshall; Luca Richeldi; Patricia J Sime; Katherine M A O'Reilly; Donna E Davies
Journal:  Oncotarget       Date:  2017-07-25

3.  Evaluation of serum lysyl oxidase as a blood test for colorectal cancer.

Authors:  S T Ward; C J Weston; E Hepburn; S Damery; R K Hejmadi; D G Morton; G Middleton; T Ismail; D H Adams
Journal:  Eur J Surg Oncol       Date:  2013-11-06       Impact factor: 4.424

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.